Communiqués

09/06 Burning Rock Reports First Quarter 2026 Financial Results AQ
28/04 Burning Rock Publishes 2025 Annual Report on Form 20-F AQ
02/04 Burning Rock Announces Founder’s Purchase of Its ADSs AQ
12/03 Burning Rock Biotech : Fourth Quarter 2025 Presentation Slides PU
12/03 Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results AQ
26/01 Burning Rock Biotech : Milestone in Precision Oncology! Burning Rock Dx’s Breast Cancer NGS CDx Kit Enters the CMDE Priority Review Channel PU
06/01 Burning Rock Biotech : Liquid Biopsy Technology Granted U.S. Patent, Accelerating Global Layout in Precision Diagnosis PU
05/01 Burning Rock Announces Founder’s Purchase of Its ADSs AQ
23/12 Burning Rock Announces Results of 2025 Annual General Meeting AQ
18/12 From Accreditation to Excellence: Webinar Highlights on CAP, CLIA, and Quality Systems in Clinical Laboratories PU
01/12 Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025 AQ
01/12 Burning Rock Biotech : BR - 2025 AGM - Notice of AGM (cfb8ff) PU
20/11 Burning Rock Reports Third Quarter 2025 Financial Results AQ
20/11 Burning Rock Biotech : Q3 2025 Presentation Slides PU
24/09/25 Burning Rock Biotech : OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer PU
18/09/25 Burning Rock Biotech : Second Quarter 2025 Financial Results PU
08/09/25 Burning Rock Reports Second Quarter 2025 Financial Results AQ
06/06/25 Burning Rock Biotech : First Quarter 2025 Financial Results PU
06/06/25 Burning Rock Biotech : First Quarter 2025 Presentation Slides PU
06/06/25 Burning Rock Reports First Quarter 2025 Financial Results AQ
25/03/25 Burning Rock Biotech : Fourth Quarter 2024 Financial Results PU
25/03/25 Burning Rock Biotech : Fourth Quarter 2024 Presentation Slides PU
25/03/25 Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results AQ
02/01/25 Burning Rock Announces Results of 2024 Annual General Meeting AQ
31/12/24 Burning Rock Biotech : Announces Results of 2024 Annual General Meeting Form 6 K PU
Aucun résultat pour cette recherche
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT